Category

NASDAQ

Via Renewables, Inc. Announces 1 for 5 Reverse Stock Split NASDAQ

Via Renewables, Inc. Announces 1 for 5 Reverse Stock Split

HOUSTON, TX / ACCESSWIRE / March 20, 2023 / Via Renewables, Inc. ("Via Renewables" or the "Company") (NASDAQ:VIA)(NASDAQ:VIASP), an independent retail energy services company, announced that its shareholders overwhelmingly approved a proposal by the Company's Board of Directors to consummate a reverse stock split of the Company'sClass A common stock,…
bubmag
March 20, 2023
Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting NASDAQ

Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting

Providing live demonstrations of a PDT procedure using the RhodoLED® lamp at booth #2224 WOBURN, MA / ACCESSWIRE / March 17, 2023 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will be hosting a booth showcasing its innovative, FDA-approved products…
bubmag
March 17, 2023
AcuityAds confirms all monies recovered from Silicon Valley Bank NASDAQ

AcuityAds confirms all monies recovered from Silicon Valley Bank

TORONTO – AcuityAds Holdings Inc. (TSX:AT, Nasdaq: ATY), a technology leader that provides targeted digital media solutions enabling advertisers to connect intelligently with audiences across advertising channels, today provided an update on its previously disclosed cash deposits with Silicon Valley Bank (SVB). The Company is pleased to report that all…
bubmag
March 16, 2023
Dermata Therapeutics Announces Pricing of $5.0 Million Public Offering NASDAQ

Dermata Therapeutics Announces Pricing of $5.0 Million Public Offering

SAN DIEGO, CA / ACCESSWIRE / March 16, 2023 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (Nasdaq:DRMA; DRMAW), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced the pricing of a public offering of 1,618,123 shares of the Company's common stock (or…
bubmag
March 16, 2023
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology NASDAQ

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology

LONDON AND HONG KONG, Mar 14, 2023 - (ACN Newswire) - Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full year ended December 31, 2022. Financial Highlights -- Revenue of US$275.8 million in…
bubmag
March 14, 2023